Omeros (OMER) – Hot FDA News
-
Omeros (OMER) says narsoplimab did not achieve statistically significant improvement over placebo in Phase 3 trial
-
Omeros (OMER) Receives Decision from FDA on Formal Dispute Resolution Request for Narsoplimab
-
-
-
-
-
-
-
-
-
-
-
Back to OMER Stock Lookup